Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 15 July 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1643911

Correction: Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery

This article is a correction to:

  1. Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery

    1. Read original article
Ziyu KangZiyu Kang1Junlin WangJunlin Wang2Jiyan LiuJiyan Liu3Li DuLi Du4Xiaofei Liu*Xiaofei Liu5*
  • 1Institute of Chinese Medical Literature and Culture, Shandong University of Chinese Medicine, Jinan, China
  • 2Department of Pharmacy, Shandong Second Provincial General Hospital, Jinan, China
  • 3Pharmacy Department, Jinan Licheng District Mental Health Prevention and Control Center, Jinan, China
  • 4Department of Acupuncture and Moxibustion, Shandong College of Traditional Chinese Medicine, Yantai, China
  • 5Breast and Thyroid Surgery, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China

A Correction on
Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery

By Kang Z, Wang J, Liu J, Du L and Liu X (2025). Front. Immunol. 16:1584087. doi: 10.3389/fimmu.2025.1584087

In the published article, there was an error in affiliation 2. Instead of “Department of Pharmacy, The Second People’s Hospital of Shandong University, Jinan, China”, it should be “Department of Pharmacy, Shandong Second Provincial General Hospital, Jinan, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: breast cancer, epigenetic modifications, immune escape, multi-omics, therapeutic targets

Citation: Kang Z, Wang J, Liu J, Du L and Liu X (2025) Correction: Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery. Front. Immunol. 16:1643911. doi: 10.3389/fimmu.2025.1643911

Received: 09 June 2025; Accepted: 07 July 2025;
Published: 15 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Kang, Wang, Liu, Du and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaofei Liu, ZHJsaXV4ZkAxMjYuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.